.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Cimetidine - Generic Drug Details

« Back to Dashboard
Cimetidine is the generic ingredient in seven branded drugs marketed by Sandoz, Ivax Sub Teva Pharms, Upsher-smith Labs, Watson Labs Inc, Glaxosmithkline, Lek Pharms, Watson Labs, Vintage Pharms Llc, Medtech Products, Dava Pharms Inc, Mylan, Apotex, Teva, Contract Pharmacal, Cycle Pharms Ltd, Pliva, Perrigo, Ani Pharms Inc, Hospira, Teva Parenteral, Luitpold, Pharm Assoc, Wockhardt, Apotex Inc, Hi Tech Pharma, and G And W Labs Inc, and is included in fifty-six NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-five drug master file entries for cimetidine. Thirty-five suppliers are listed for this compound.

Summary for Generic Name: cimetidine

Tradenames:7
Patents:0
Applicants:26
NDAs:56
Drug Master File Entries: see list25
Suppliers / Packaging: see list35
Therapeutic Class:Gastrointestinal Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices

Pharmacology for Ingredient: cimetidine

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ivax Sub Teva Pharms
CIMETIDINE
cimetidine
TABLET;ORAL074424-001Jul 28, 1995DISCNNo► subscribe► subscribe
Luitpold
CIMETIDINE HYDROCHLORIDE
cimetidine hydrochloride
INJECTABLE;INJECTION074353-001Dec 20, 1994DISCNNo► subscribe► subscribe
Mylan
CIMETIDINE
cimetidine
TABLET;ORAL074246-004May 17, 1994RXYes► subscribe► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: cimetidine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline
TAGAMET
cimetidine
TABLET;ORAL017920-002Approved Prior to Jan 1, 19823,950,333► subscribe
Glaxosmithkline
TAGAMET
cimetidine
TABLET;ORAL017920-004Dec 14, 19833,950,333► subscribe
Glaxosmithkline
TAGAMET
cimetidine
TABLET;ORAL017920-005Apr 30, 19863,950,333► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc